+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dextran"

From
From
Anemia Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Anemia Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
Iron Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Iron Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Intravenous Iron Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Intravenous Iron Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Intravenous Iron Drugs Market Report 2025 - Product Thumbnail Image

Intravenous Iron Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Intravenous (IV) Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Intravenous (IV) Iron Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 354 Pages
  • Global
From
From
Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029 - Product Thumbnail Image

Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029

  • Report
  • February 2024
  • 126 Pages
  • Global
From
From
From
Blood Substitutes - Product Thumbnail Image

Blood Substitutes

  • Book
  • October 2005
  • 20 Results (Page 1 of 1)
Loading Indicator

Dextran is a polysaccharide used in hematological drugs, primarily as a plasma expander. It is used to treat conditions such as hypovolemia, anemia, and thrombocytopenia. It is also used to reduce the risk of blood transfusions and to reduce the risk of complications from surgery. Dextran is available in a variety of formulations, including intravenous, intramuscular, and oral. The dextran market is a growing segment of the hematological drugs market. It is used in a variety of medical applications, including the treatment of anemia, thrombocytopenia, and hypovolemia. It is also used to reduce the risk of blood transfusions and to reduce the risk of complications from surgery. Some of the companies in the dextran market include Baxter International, Fresenius Kabi, B. Braun Melsungen AG, Grifols, and Octapharma. Show Less Read more